[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Covenant Health, US\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100610030","clinical-trial-protocol-alzheimers-dementia-underlying-encephalopathy-100610030",false,"NCT07222280","Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy","Inclusion Criteria:\n\n* Ages 60 to 90 years old\n* No prior diagnosis of dementia\n* Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a toxic\u002Fmetabolic state\n\nExclusion Criteria:\n\n* Age under 60 years\n* Prior diagnosis of dementing illness or other organic etiology to cognitive impairment","ALL","60 Years","90 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease.\n\n* Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting?\n* Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzheimer's Disease blood test completed while they were inpatient to discuss the risk assessment portfolio",[26,27,28,29,30],"Alzheimer Dementia","Alzheimer Disease","Delirium Confusional State","Encephalopathy","Cognitive Abnormality","RECRUITING","2025-10-27",{"date":34,"type":35},"2025-10-29","ACTUAL",{"date":37,"type":35},"2025-06-10",{"date":39,"type":20},"2026-03-31",{"name":41,"class":42},"Covenant Health, US","OTHER",6,""]